Related Experiment Video
Updated: Feb 4, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51
Guohong Liu1, Mingxia Yu2, Balu Wu3
1Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China.
Abstract:
Jab1 overexpression correlates with poor prognosis in breast cancer patients, suggestting that targeting the aberrant Jab1 signaling in breast cancer could be a promising strategy. In the current study, we investigate the hypothesis that Jab1 positively regulates the DNA repair protein Rad51 and, in turn, the cellular response of breast cancer to chemotherapy with adriamycin and cisplatin. High-throughput mRNA sequencing (RNA-Seq) data from 113 normal and 1109 tumor tissues (obtained from TCGA) were integrated to our analysis to give further support to our findings. We found that Jab1 was overexpressed in adriamycin-resistant breast cancer cell MCF-7R compared with parental MCF-7 cells, and that knockdown of Jab1 expression conferred cellular sensitivity to adriamycin and cisplatin both in vivo and in vitro. By contrast, exogenous Jab1 expression enhanced the resistance of breast cancer cells to adriamycin and cisplatin. Moreover, we discovered that Jab1 positively regulated Rad51 in p53-dependent manner and that overexpression of Rad51 conferred cellular resistance to adriamycin and cisplatin in Jab1-deficient cells. Data from TCGA further validated an correlation between Jab1 and Rad51 in breast cancer, and elevated Jab1 and Rad51 associated with poor survival in breast cancer patients. Our findings indicate that Jab1 association with Rad51 plays an important role in cellular response to chemotherapy in breast cancer.
Insights
Targeting Jab1 (Jun activation domain-binding protein 1) could improve breast cancer chemotherapy. Jab1 promotes DNA repair protein Rad51, enhancing resistance to adriamycin and cisplatin, and is linked to poor patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Jab1 overexpression is linked to poor prognosis in breast cancer.
- Targeting Jab1 signaling presents a potential therapeutic strategy for breast cancer.
Purpose of the Study:
- To investigate the role of Jab1 in regulating the DNA repair protein Rad51.
- To determine the impact of Jab1 on breast cancer response to chemotherapy drugs adriamycin and cisplatin.
Main Methods:
- Utilized high-throughput mRNA sequencing (RNA-Seq) data from The Cancer Genome Atlas (TCGA).
- Compared Jab1 expression in adriamycin-resistant vs. parental breast cancer cells (MCF-7R vs. MCF-7).
- Assessed the effects of Jab1 knockdown and overexpression on cellular sensitivity to chemotherapy in vitro and in vivo.
Main Results:
- Jab1 was overexpressed in adriamycin-resistant MCF-7R cells.
- Knockdown of Jab1 increased sensitivity to adriamycin and cisplatin.
- Exogenous Jab1 expression enhanced chemoresistance.
- Jab1 positively regulated Rad51 in a p53-dependent manner.
- Rad51 overexpression conferred chemoresistance in Jab1-deficient cells.
- TCGA data confirmed a correlation between Jab1 and Rad51, associated with poor patient survival.
Conclusions:
- Jab1 positively regulates Rad51, influencing breast cancer cell response to chemotherapy.
- The Jab1-Rad51 association is a critical factor in chemotherapy resistance in breast cancer.
- Targeting Jab1 may represent a viable strategy to overcome chemoresistance in breast cancer patients.
Related Concept Videos
Binet's Contribution to Measures of Intelligence
Wechsler's Contribution to Measures of Intelligence
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Epigenetic Regulation
GTPases and their Regulation
Large G-proteins,...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

